According to news on May 17, in March 2022, Hangzhou Huajiang Medical Robot Co., Ltd. (“Huajian Medical Robot”), an innovative enterprise of minimally invasive surgical robots, completed tens of millions of RMB in Series A financing. This round of financing was funded by Puhua Capital and Oriental Fortune Co., Ltd. jointly led the investment, and Westlake Ventures participated in the investment. This round of financing is aimed at accelerating the development, clinical and commercialization of related core products.
Huajiang Medical Robot was established in July 2020 with 65 employees and is headquartered in Xihu District, Hangzhou City. Different from the traditional product design ideas of domestic manufacturers that highly imitate the “Da Vinci” robot, Huajiang is committed to using new technologies to redefine the next generation of surgical robots for the future, as well as using robot technology to empower, upgrade and transform traditional medical devices to meet clinical needs. diverse needs and inclusive needs. The company has completed the construction of three major product systems: bendable instruments, holding robots and surgical robots, many of which have entered the inspection/clinical/forensics stage. At the same time, the company has declared 30 patents, of which 12 patents have been authorized.
media coverage
Investment Community Yiou Investment China Network
This article is reproduced from: https://readhub.cn/topic/8g5cSTFzjxi
This site is for inclusion only, and the copyright belongs to the original author.